Back to search

Belgium· BE-AMP-SAM511857-00

Olmesartan/Amlodipine Daiichi Sankyo 20 mg - 5 mg

A olmesartan medoxomil und amlodipin product containing olmesartan medoxomil, registered in Belgium by Sankyo Pharma Belgium. The same ATC class is registered in 8 of our 19 countries.

ATC C09DB02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedOlmesartan/Amlodipine Daiichi Sankyo …ATCC09DB02REGISTER NO.BE-AMP-SAM511857-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Olmesartan medoxomil und amlodipin is registered in 8 of 19 countries.

Countries holding a registration under ATC C09DB02 (olmesartan medoxomil und amlodipin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Olmesartan medoxomil und amlodipin · ATC C09DB02

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Olmesartan Medoxomil
Manufacturer
Sankyo Pharma Belgium
Country
Belgium (BE)
ATC code
C09DB02
ATC class
Olmesartan medoxomil und Amlodipin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for olmesartan medoxomil und amlodipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Olmesartan medoxomil und amlodipin · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Olmesartan medoxomil und amlodipin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil und amlodipin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Mencord, Olmeblo
  • Bulgaria · Tansidor, Амлосарт
  • Cyprus · Olmesartan Medoxomil Jubilant, Olmesartan Tad
  • Czechia · Sarten, Zeota
  • Germany · Olmecor, Olmes
  • Denmark · Olmesartan Medoxomil Krka
  • Estonia · Mesar, Olimestra
  • Spain · Atolme, Ixia
  • Finland · Olmesartan Medoxomil Krka, Olmesartan Medoxomil Stada
  • France · Alteis, Olmetec
  • United Kingdom (Northern Ireland) · Olmesartan, Olmesartan Glenmark Pharmaceuticals Europe
  • Greece · Ipertas, Olmesartan Sandoz
  • Croatia · Olimestra, Olmesartan Genericon
  • Hungary · Laresin
  • Ireland · Olmesartan Krka, Olmesartan Medoxomil Accord Healthcare
  • Italy · Cardol, Idalman
  • Lithuania · Mesar, Olimestra
  • Luxembourg · Belsar, Olmesartan Eg
  • Latvia · Mesar, Olimestra
  • Malta · Olmesartan Aurobindo Pharma (Malta), Olmesartan Vocate
  • Netherlands · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Aurobindo
  • Norway · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Krka
  • Poland · Olimestra, Olmesartan Lek-Am
  • Portugal · Atolme, Condronac
  • Romania · Olmetec, Santini
  • Slovenia · Olimestra, Tensiol
  • Slovakia · Tenzar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f11ca193-eb5a-40bf-890d-1ee056b9bd11
GET /v1/drugs/f11ca193-eb5a-40bf-890d-1ee056b9bd11?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Olmesartan/Amlodipine Daiichi Sankyo 20 mg - 5 mg",
  "name_fr": "Olmesartan/Amlodipine Daiichi Sankyo 20 mg - 5 mg",
  "name_nl": "Olmesartan/Amlodipine Daiichi Sankyo 20 mg - 5 mg",
  "amp_code": "SAM511857-00",
  "strengths": [
    "20.0000",
    "6.9440",
    "5.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Olmesartan Medoxomil",
    "Amlodipine Besilate",
    "Amlodipine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Olmesartan Medoxomil and Amlodipine",
  "authorisation_numbers": [
    "BE511857"
  ]
}

See everything about olmesartan medoxomil und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.